Summary:
This trial's goal is to reduce LDL-C in individuals who already have a LDL-C of 70 or higher and are currently on medication for there cholesterol, by using an additional therapy. We are looking for participants who have type 2 diabetes, or who have metabolic disease. Metabolic disease may look like high blood pressure, high BMI, medication to reduce glucoses, or others risk factors.
Qualified Participants Must:
18 years or older
Currently on Lipid lowering medication
Have type 2 diabetes or have metabolic disease
Qualified Participants May Receive:
Participants are compensated based on visits completes within the trial.